דוסטקסל ג'נמדיקס

Land: Israel

Språk: hebreiska

Källa: Ministry of Health

Aktiva substanser:

DOCETAXEL 20 MG/ML

Tillgänglig från:

GENMEDIX

ATC-kod:

L01CD02

Läkemedelsform:

CONCENTRATE FOR SOLUTION FOR INFUSION

Administreringssätt:

I.V

Tillverkad av:

SINDAN PHARMA SRL, ROMANIA

Terapeutisk grupp:

DOCETAXEL

Terapeutiska indikationer:

Breast cancer: docetaxel in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with operable node- positive breast cancer. docetaxel in combination with doxorubicin is indicated for the treatment of patients with locally advanced or metastatic breast cancer who have not previously received cytotoxic therapy for this condition. docetaxel monotherapy is indicated for the treatment of patients with metastatic breast cancer after failure of cytotoxic therapy. Previous chemotherapy should have included an anthracycline or an alkylating agent. docetaxel in combination with trastuzumab is indicated for the treatment of patients with metastatic breast cancer whose tumors overexpress HER2 and who previously have not received chemotherapy for metastatic disease. docetaxel in combination with capecitabine is indicated for the treatment of patients with metastatic breast cancer after failure of cytotoxic chemotherapy. Previous therapy should have included an anthracyclin

Tillstånd datum:

2011-10-01